We are live on ! Find out more

13 hedge funds and large institutions have $275K invested in iBio in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more funds holding

Funds holding: 1013 (+3)

0% less ownership

Funds ownership: 0.01%0% (-0%)

30% less capital invested

Capital invested by funds: $393K → $275K (-$118K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change

IBIO Hedge Fund Activity: Q3 2018 in Review

13 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2018, worth a combined $275K — down 30% from $393K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IBIO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $15.4K. The largest seller was SignatureFD, cutting an estimated $111K.

  • 13 institutional investors held iBio (IBIO) as of Q3 2018, up from 10 in Q2 2018.
  • Funds reported $275K of iBio stock for Q3 2018, down 30% quarter-over-quarter.
  • 3 funds opened new iBio positions in Q3 2018 and 0 closed out, a net change of +3 holders.
  • The largest iBio buyer in Q3 2018 was Two Sigma Securities, an estimated $15.4K added.
  • The largest iBio seller in Q3 2018 was SignatureFD, an estimated $111K sold.

Based on aggregated 13F filings for Q3 2018.